http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9603991-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77b8d2a63ff4378924f2b92913125f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9deadbe8a85365e29435518b9dd957ad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
filingDate 1995-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a23d996efb8423f94620491eb51d3db
publicationDate 1996-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9603991-A1
titleOfInvention Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence
abstract Description of pharmaceutical or cosmetic compositions aimed at improving the local microcirculation of the penis for chronic topical treatment of vascular impotence due to vascular causes, with main impairment of the arterial-arteriolar afferents of the cavernous bodies. The new pharmacological properties of the complex between PGE1 and/or Troxerutine with Phosphatidylcholine are administered locally on the skin of the penis; the activity is obtained using the T.E.B. system according to Curri.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0874622-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6589990-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0874622-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5718917-A
priorityDate 1994-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9503787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4125255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60260524-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0459377-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420444130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127511468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19037215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129001639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426088935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227044919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227044918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17848643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129673427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129346490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11963115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9942151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454446249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226576460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426081333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263

Total number of triples: 79.